Literature DB >> 7705823

Prognostic significance of MUC1 epithelial mucin expression in breast cancer.

M A McGuckin1, M D Walsh, B G Hohn, B G Ward, R G Wright.   

Abstract

The epithelial mucin produced by the MUC1 gene is present in the apical cell membrane of normal breast epithelial cells and is highly expressed in many breast cancers. Several studies have provided conflicting evidence regarding the relationship between MUC1 expression and survival in breast cancer patients. In this study a detailed immunohistological analysis of MUC1 expression was performed using monoclonal antibody BC2 and was related to other tumor characteristics and patient survival. Patients whose tumors showed MUC1 expression in greater than 75% of tumor cells had significantly poorer disease-free and overall survival (P < .05). The proportion of cells showing cytoplasmic MUC1 expression was prognostically significant, but the proportion of cells that lined gland spaces showing apical membrane staining was of no prognostic significance. A high level of MUC1 expression was significantly associated with the presence of axillary node metastases and estrogen receptors but not with other tumor characteristics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705823     DOI: 10.1016/0046-8177(95)90146-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  52 in total

1.  Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.

Authors:  Carol L Kinlough; Paul A Poland; Sandra J Gendler; Polly E Mattila; Di Mo; Ora A Weisz; Rebecca P Hughey
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

3.  O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.

Authors:  Pushpa Premaratne; Karin Welén; Jan-Erik Damber; Gunnar C Hansson; Malin Bäckström
Journal:  Tumour Biol       Date:  2010-09-26

4.  Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

Authors:  A Bergeron; H LaRue; Y Fradet
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.

Authors:  F Guddo; A Giatromanolaki; M I Koukourakis; C Reina; A M Vignola; G Chlouverakis; J Hilkens; K C Gatter; A L Harris; G Bonsignore
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

6.  Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues.

Authors:  M B Pereira; A J Dias; C A Reis; F C Schmitt
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 7.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Immunohistopathological characterizatin of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft.

Authors:  M V Croce; A G Colussi; M G De Bravo; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature.

Authors:  Sandra O Demichelis; Marina T Isla-Larrain; Luciano Cermignani; Cecilio G Alberdi; Amada Segal-Eiras; María Virginia Croce
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-12-20

10.  Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Authors:  Mark D Pegram; Virginia F Borges; Nuhad Ibrahim; Jyotsna Fuloria; Charles Shapiro; Susan Perez; Karen Wang; Franziska Schaedli Stark; Nigel Courtenay Luck
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.